Evidence map›Paper›PMID 15452684›Full record

Trial reportPsychopharmacology2005

Risperidone diminishes cocaine-induced craving.

Richard De La Garza, Thomas F Newton, Ari D Kalechstein

Abstract readClinical TrialControlled Clinical TrialLetter
PubMed Publisher
In one paragraph

Trial report in Psychopharmacology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. A qualitative and quantitative review of cocaine-induced craving: the phenomenon of priming.Progress in neuro-psychopharmacology & biological psychiatry · 2007
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Richard De La Garza
Thomas F Newton
Ari D Kalechstein

Funding

ZDV &3TC NEVIRAPINE COMBINATION THERAPY IN HIV 1 INFECTED INFANTS &M01RR000865 · NCRR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WASHINGTON, ARNOLD E. · 1985 to 2011
$43.4M
UCLA DRUG ABUSE RESEARCH TRAINING PROGRAMT32DA007272 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GRELLA, CHRISTINE E · 1991 to 2017
$4.9M
NCRR NIH HHS M01 RR00865NIDA NIH HHS DA00388NIDA NIH HHS DA07272NIDA NIH HHS DA50038
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MotivationAdultAntipsychotic AgentsCocaine-Related DisordersDopamine D2 Receptor AntagonistsDose-Response Relationship, DrugDrug Administration ScheduleFemaleHumansMaleMiddle AgedPremedicationRisperidoneSerotonin 5-HT2 Receptor AntagonistsSubstance Abuse, IntravenousAntipsychotic AgentsDopamine D2 Receptor AntagonistsRisperidoneSerotonin 5-HT2 Receptor Antagonists

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.